P38 MAPK-IN-4
P38 MAPK-IN-4 (compound 6) is a p38 MAPK inhibitor with an IC50 of 35 nM[1].
Product Specifications
CAS Number
219138-24-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
P38 MAPK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/p38-mapk-in-4.html
Purity
98.69
Solubility
DMSO : 20 mg/mL (ultrasonic; adjust pH to 2 with 1M HCl)
Smiles
O=C1N(C2=CC=C(Cl)C=C2)NC(C3=CC=NC=C3)=C1C4=CC=C(F)C=C4
Molecular Formula
C20H13ClFN3O
Molecular Weight
365.79
Precautions
H302, H315, H319
References & Citations
[1]S E de Laszlo, et al. Pyrroles and other heterocycles as inhibitors of p38 kinase. Bioorg Med Chem Lett. 1998 Oct 6;8 (19) :2689-94.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
P38 MAPK
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400008-500 1x 500 µL
MAGE A1 (MA454), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680017-100 1x 100 µL
Ep-CAM / CD326 (VU-1D9), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 